Clinical and experimental rheumatologyHumansFamilial Mediterranean FeverInterleukin 1 Receptor Antagonist ProteinMaleFemale
A single dose of anakinra for arresting familial Mediterranean fever attacks: a proof-of-concept study.
Eitan Giat, Avi Livneh, Ilan Ben-Zvi, Amit Druyan, Danielle Bar, David J Ozeri, Galit Almoznino, Merav Lidar
Published: 202510.55563/clinexprheumatol/cj61ub
Abstract
OBJECTIVES: Familial Mediterranean fever (FMF) is characterised by painful inflammatory bouts, typically lasting one to three days. Analgesics, the only available treatment to alleviate acute attacks, are often ineffective in reducing pain and attack…
Preview only. Read the full abstract at the source